A detailed history of Tkg Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Tkg Advisors, LLC holds 75,447 shares of PFE stock, worth $2.19 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
75,447
Previous 76,121 0.89%
Holding current value
$2.19 Million
Previous $2.11 Million 0.05%
% of portfolio
1.17%
Previous 1.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $17,025 - $19,950
-674 Reduced 0.89%
75,447 $2.11 Million
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $647,508 - $743,547
25,010 Added 48.93%
76,121 $2.11 Million
Q4 2023

Feb 23, 2024

BUY
$26.13 - $33.94 $28,507 - $37,028
1,091 Added 2.18%
51,111 $1.47 Million
Q3 2023

Nov 02, 2023

BUY
$32.09 - $37.51 $48,423 - $56,602
1,509 Added 3.11%
50,020 $1.66 Million
Q2 2023

Jul 20, 2023

BUY
$36.12 - $41.79 $1.75 Million - $2.03 Million
48,511 New
48,511 $1.78 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Tkg Advisors, LLC Portfolio

Follow Tkg Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tkg Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tkg Advisors, LLC with notifications on news.